Stock ORIC ORIC PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart ORIC Pharmaceuticals, Inc.

Equities

ORIC

US68622P1093

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
9.17 USD +6.01% Intraday chart for ORIC Pharmaceuticals, Inc. +8.52% -0.33%
May. 06 ORIC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 15 ORIC Pharmaceuticals Doses First Patients in Expansion Groups in Phase 1b Trial of ORIC-114 to Treat Lung Cancer MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ORIC PHARMACEUTICALS, INC. Stock ORIC Pharmaceuticals, Inc.
 618M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 109B
BIONTECH SE Stock BioNTech SE
 24.74B -
ARGENX SE Stock argenx SE
 22.67B -
GENMAB A/S Stock Genmab A/S
 18.14B
  1. Stock Market
  2. Equities
  3. ORIC Stock
  4. Charts ORIC Pharmaceuticals, Inc.
  5. Sector Chart